Anixa (ANIX) Director Arnold M. Baskies Buys 5,000 Shares

What Happened

• Arnold M. Baskies, a director of Anixa Biosciences, acquired 5,000 common shares on 2026-09-24 at $2.76 per share, for a total cost of $13,800. The Form 4 reports this as a purchase (code P), described as an open-market or private purchase.
• Purchases by directors are often watched by investors as a potentially positive signal, though this note is factual and does not speculate on motive.

Key Details

• Transaction date and price: 2026-09-24 — 5,000 shares @ $2.76 each (total $13,800).
• Filing: Form 4 filed 2026-09-28 (Accession: 0001493152-26-044457); filing appears timely (filed within the 2-business-day window).
• Shares owned after transaction: Not specified in the details provided here — check the full Form 4 for the "Amount Owned Following Reported Transaction" field.
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other footnotes were provided in the summary supplied.

Context

• This was a straightforward purchase by a company director. For retail investors, director purchases can be one data point among many when assessing insider sentiment; always combine with company fundamentals and broader insider activity.
• If you need the exact post-transaction ownership or any footnotes, review the full SEC Form 4 (Accession 0001493152-26-044457) for complete disclosure.